United States · FDA National Drug Code directory

Low Vaccinosis Nosode 4024

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 63083-4024_0b1eb38f-cd7f-4d11-85c4-b2b065614c1c
Product NDC: 63083-4024
Form: LIQUID
Composition / generic term: Low Vaccinosis Nosode
Labeler: Professional Complementary Health Formulas
Marketing category: UNAPPROVED HOMEOPATHIC
Marketing start / end (source format): 19840815
Source listing expiry: 20271231

Source-listed ingredients

OYSTER SHELL CALCIUM CARBONATE, CRUDE — 6 [hp_X]/59mL
SILICON DIOXIDE — 6 [hp_X]/59mL
THUJA OCCIDENTALIS LEAF — 6 [hp_X]/59mL
LAURTRIMONIUM BROMIDE — 9 [hp_X]/59mL
MUMPS VIRUS — 9 [hp_X]/59mL
CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) — 9 [hp_X]/59mL
ANGUILLA ROSTRATA BLOOD SERUM — 12 [hp_X]/59mL
SERUM, HORSE — 12 [hp_X]/59mL

These values do not establish equivalence or a dose recommendation.

Packages

59 mL in 1 BOTTLE, DROPPER (63083-4024-2) · 63083-4024-2

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →